Pediatric anxiety - Underrecognized and undertreated

New England Journal of Medicine

Volumn 359, Issue 26, 2008, Pages 2835-2836

  Emslie, Graham J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDITORIAL; FEAR; HEADACHE; HUMAN; PHOBIA; PRIORITY JOURNAL; SEPARATION ANXIETY; SOCIAL BEHAVIOR; STOMACH PAIN;

EID: 58149093744     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0809401     Document Type: Editorial

References (6)

1. Costello EJ, Egger HL, Angold A. Developmental epidemiology of anxiety disorders. In: Ollendick TH, March JS, eds. Phobic and anxiety disorders in children and adolescents. New York: Oxford University Press, 2004:61-91.
2. Woodward LJ, Fergusson DM. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 2001;40:1086-93.
3. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:2753-66.
4. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, DC: American Psychiatric Association, 1994.
5. Birmaher B, Axelson DA, Monk K, et al. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42:415-23.
6. Dadds MR, Holland DE, Laurens KP, Mullins M, Barrett PM, Spence SH. Early intervention and prevention of anxiety disorders in children: results at two-year follow-up. J Consult Clin Psychol 1999;67:145-50.